SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA token is trending as investors grapple with a massive price collapse, with community discourse dominated by accusations of a pump-and-dump scheme linked to the Trump family. Skeptical traders are actively debating the token's near-zero value while warning others about the recurring pattern of losses associated with politically-themed meme coins.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is trending as investors digest the recent $65M public offering and the signing of a major GPU-as-a-Service contract with Hydra Host. The community is actively debating the potential for an M&A or joint venture with TSSI to scale edge AI infrastructure, alongside bullish sentiment surrounding the company's modular data center strategy and new leadership's ability to drive rapid deal flow.

Adecoagro SA is a holding company, which engages in the provision of agricultural and agro-industrial products and services. It operates through the following segments: Farming, Sugar, Ethanol and Energy, and Land Transformation. The Farming segment is comprised of three reportable segments Crops, Rice and Dairy. The Crops Segment consists of planting, harvesting and sale of grains, oilseeds and fibers. The Rice segment consists of planting, harvesting, processing and marketing of rice. The Dairy segment consists of the production and sale of raw milk and industrialized products, including UHT, cheese and powder milk among others. The Sugar, Ethanol, and Energy Segment consists of cultivating sugarcane which is processed in owned sugar mills, transformed into ethanol, sugar and electricity and then marketed. The Land Transformation segment comprises of identification and acquisition of underdeveloped and undermanaged farmland businesses; and realization of value through the strategic disposition of assets. The company was founded by Alan Leland Boyce, Ezequiel Garbers, Mariano Bosch, and Walter Marcelo Sanchez in September 2002 and is headquartered in Luxembourg.

Adecoagro S.A.

Adecoagro is trending as investors focus on the company's strategic integration of agricultural production and fertilizer operations under the significant ownership stake of Tether. The community is actively discussing the firm's role as a potential geopolitical hedge amid global supply chain disruptions and its expansion into alternative energy and infrastructure.

Direxion Shares ETF Trust - Direxion Small Cap Bear 3X ETF

Direxion Daily Small Cap Bear 3X Shares

TZA is trending as traders hedge against small-cap volatility and potential market reversals, with the community actively debating the impact of tariff uncertainty, government funding concerns, and the fundamental decay inherent in triple-leveraged inverse ETFs. While some investors view recent price action as a technical opportunity to play a market correction, others warn of the structural risks and time-decay associated with holding such instruments for the long term.

Direxion Shares ETF Trust - Direxion Small Cap Bull 3X ETF

Direxion Daily Small Cap Bull 3X Shares

TNA is trending as investors monitor increased rotation into small-cap equities, driven by persistent optimism regarding potential Federal Reserve interest rate cuts and broader economic shifts. Traders are actively discussing the index's technical performance and using the volatility of this leveraged ETF for short-term swing plays, while others are closely watching for a potential breakout to higher price levels.

Bitcoin SV (BSV) emerged following a hard fork of the Bitcoin Cash (BCH) blockchain in 2018, which had in turn forked from the BTC blockchain a year earlier. The goal of Bitcoin SV is to fulfil the original vision of the Bitcoin protocol and design as described in Satoshi Nakamoto’s white paper, early Bitcoin client software and known Satoshi writings. BSV aims to offer scalability and stability in line with the original description of Bitcoin as a peer-to-peer electronic cash system, as well as deliver a distributed data network that can support enterprise-level advanced blockchain applications. To this end, it has removed artificial block size limits and re-enabled Script commands and other technical capabilities which had been historically disabled or restricted by the protocol developers of the BTC blockchain. This allows the network to process tens of thousands of transactions per second while maintaining extremely low transaction fees for micropayments, in addition to offering advanced capabilities such as tokens, smart contracts, computation and other data use cases. The BSV network is unique in its capacity for unbounded on-chain scaling while also being more aligned with the original design of Bitcoin than any other blockchain.

Bitcoin SV

Bitcoin SV is currently generating intense community debate as participants weigh the implications of the ongoing legal proceedings surrounding Craig Wright, with bullish supporters pointing to recent scalability milestones like Teranode and the protocol's adherence to the original whitepaper. Conversely, many are dismissing the project as a fraudulent endeavor, highlighting delistings from major exchanges and a general detachment from the broader market sentiment surrounding Bitcoin.

Scotts Miracle-Gro Co. engages in the manufacturing, marketing, and sale of products for lawn and garden care and indoor and hydroponic gardening. The firm’s products and services include lawn care, gardening and landscape, hydroponic hardware and growing environments, lighting, controls, and marketing agreement. It operates through the following segments: U.S. Consumer, Hawthorne, and Other. The U.S. Consumer and Other segments manufacture and market branded consumer lawn and garden products. The U.S. Consumer segment consists of consumer lawn and garden business in the United States. The Hawthorne segment manufactures, markets, and distributes lighting, nutrients, growing media, growing environments, and hardware products for indoor and hydroponic gardening in North America. The company was founded by Orlando McLean Scott in 1868 and is headquartered in Marysville, OH.

Scotts Miracle-Gro Company - Ordinary Shares - Class A

Scotts Miracle-Gro Company

Scotts Miracle-Gro is seeing increased market chatter as investors debate the impact of potential cannabis industry rescheduling and the company's efforts to stabilize its balance sheet. Community discussion remains polarized, with some traders monitoring seasonal demand for lawn and garden products while others express frustration over management's past expansion into hydroponics and the stock's recent volatility.

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.

Surrozen Inc

Surrozen is trending as investors anticipate key Phase 1 clinical data for its SZN-043 liver cirrhosis program and updates on its ophthalmology collaborations. The community is heavily focused on potential buyout prospects and the company's long-term value, with active discussions comparing its Wnt-modulating technology to recent successful acquisitions in the sector.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding Company is under intense scrutiny and market pressure following the unsealing of a lawsuit against BNY Mellon and others, which alleges a massive fraudulent scheme involving the unauthorized sale of pledged collateral shares. Investors are sharply divided, with some community members decrying the situation as another chapter in a long history of mismanagement and deceptive practices, while others express cautious optimism that the legal action signals a decisive fight against short sellers and an eventual recovery of corporate assets.

Direxion Shares ETF Trust - Direxion Daily TSLA Bear 1X ETF

Direxion Daily TSLA Bear 1X Shares

TSLS is trending as traders closely monitor technical indicators and sentiment surrounding Tesla, with many in the community debating the efficacy of holding leveraged bear ETFs amidst volatile price action and potential reverse splits. Market participants are actively discussing the stock's sensitivity to Tesla's operational performance, inventory levels, and broader sector trends as investors weigh the risks of decay in these inverse products against the prospect of a market pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Average Recommendation of "Hold" from Analysts

Keros Therapeutics, Inc. (NASDAQ:KROS - Get Free Report) has been assigned a consensus recommendation of "Hold" from the ten analysts that are presently covering the company, Marketbeat reports. One...

Q1 EPS Estimate for Keros Therapeutics Decreased by Analyst

Keros Therapeutics, Inc. (NASDAQ:KROS - Free Report) - HC Wainwright decreased their Q1 2026 earnings per share estimates for Keros Therapeutics in a report released on Thursday, March 5th. HC...

Keros Therapeutics (NASDAQ:KROS) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of Keros Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

Can Keros Therapeutics Rinvatercept Stand Out in the DMD Market?

KROS advances rinvatercept for Duchenne muscular dystrophy, with a phase II trial planned for 2026 after gaining FDA orphan drug designation.

What is HC Wainwright's Estimate for KROS FY2030 Earnings?

Keros Therapeutics, Inc. (NASDAQ:KROS - Free Report) - Analysts at HC Wainwright issued their FY2030 earnings per share estimates for Keros Therapeutics in a research report issued to clients and...

Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?

Reblozyl tops $2.3B in annualized sales, emerging as a key drug for Bristol Myers as demand rises in MDS-related anemia and new study data support expansion.

Wells Fargo & Company Cuts Keros Therapeutics (NASDAQ:KROS) Price Target to $20.00

Wells Fargo & Company cut their price target on Keros Therapeutics from $23.00 to $20.00 and set an "overweight" rating for the company in a report on Thursday...

Keros Therapeutics, Inc. (KROS) Reports Q4 Loss, Misses Revenue Estimates

Keros Therapeutics (KROS) delivered earnings and revenue surprises of -75.51% and -94.08%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Keros Therapeutics (NASDAQ:KROS) Announces Quarterly Earnings Results

Keros Therapeutics (NASDAQ:KROS - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.86) earnings per share (EPS) for the quarter, missing analysts' consensus...

Keros Therapeutics Touts Rinvat ercept DMD Trial Start, Eyes ALS Phase II Talks at Oppenheimer Conference

Keros Therapeutics (NASDAQ:KROS) CEO Jasbir Seehra outlined the company's development priorities and partnership plans during a presentation at Oppenheimer's 36th Annual Healthcare Life Sciences...

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.

KROS
Keros Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KROS News

KROSKeros Therapeutics Inc